Course Website Locator: epi221-01

Harvard School of Public Health

The following course websites match your request:

Fall 2 2009

Dr. A. Walker
2.5 credits
Lectures. Four 2-hour lectures each week.

Within the framework of formal epidemiologic analysis, this course covers inference about the effects of pharmaceuticals from case reports, case series, vital statistics and other registration schemes, cohort studies, and case-control studies. Decision-making with inadequate data is examined from the perspectives of manufacturers and of regulators. Students are graded on the basis of group projects. This course is intended primarily for students wishing to pursue a career in the pharmaceutical industry or in national regulatory bodies, but may have more general interest as an applied mid-level course with a heavy methodological emphasis.
Course Activities: Written and oral group projects, individual class presentations, class discussion.

Course Note: Knowledge of epidemiology at the level of EPI 202 and a basic understanding of drug use and nomenclature are assumed; completion of EPI203 preferred; enrollment limited to 25 students; signature of instructor required.

Course evaluations are an important method for feedback on the quality of course offerings. The submission of a course evaluation is a requirement for this course. Your grade for the course will be made available only after you have submitted responses to at least the first three questions of the on-line evaluation for this course.

Fall 2 2008

Dr. A. Walker
2.5 credits
Lectures. Four 2-hour lectures each week.

Within the framework of formal epidemiologic analysis, this course covers inference about the effects of pharmaceuticals from case reports, case series, vital statistics and other registration schemes, cohort studies, and case-control studies. Decision-making with inadequate data is examined from the perspectives of manufacturers and of regulators. Students are graded on the basis of group projects. This course is intended primarily for students wishing to pursue a career in the pharmaceutical industry or in national regulatory bodies, but may have more general interest as an applied mid-level course with a heavy methodological emphasis.
Course Activities: Written and oral group projects, individual class presentations, class discussion.

Course Note: Knowledge of epidemiology at the level of EPI 202 and a basic understanding of drug use and nomenclature are assumed; completion of EPI203 preferred; enrollment limited to 25 students; signature of instructor required.

Course evaluations are an important method for feedback on the quality of course offerings. The submission of a course evaluation is a requirement for this course. Your grade for the course will be made available only after you have submitted responses to at least the first three questions of the on-line evaluation for this course.

Winter 2008

Dr. A. Walker
2.5 credits
Lectures. Four 2.5-hour sessions each week.

Within the framework of formal epidemiologic analysis, this course covers inference about the effects of pharmaceuticals from case reports, case series, vital statistics and other registration schemes, cohort studies, and case-control studies. Decision-making with inadequate data is examined from the perspectives of manufacturers and of regulators. Students are graded on the basis of group projects. This course is intended primarily for students wishing to pursue a career in the pharmaceutical industry or in national regulatory bodies, but may have more general interest as an applied mid-level course with a heavy methodological emphasis.
Course Activities: Written and oral group projects, individual class presentations, class discussion.
Course Note: Knowledge of epidemiology at the level of EPI 202 and a basic understanding of drug use and nomenclature are assumed; completion of EPI203 preferred; enrollment limited to 25 students; signature of instructor required; course meets Monday through Thursday, 1:30 pm to 4 pm during WinterSession. (5.06)

Course evaluations are an important method for feedback on the quality of course offerings. The submission of a course evaluation is a requirement for this course. Your grade for the course will be made available only after you have submitted responses to at least the first three questions of the on-line evaluation for this course.

Winter 2007

Dr. A. Walker
2.5 credits
Lectures. Four 2.5-hour sessions each week.

Within the framework of formal epidemiologic analysis, this course covers inference about the effects of pharmaceuticals from case reports, case series, vital statistics and other registration schemes, cohort studies, and case-control studies. Decision-making with inadequate data is examined from the perspectives of manufacturers and of regulators. Students are graded on the basis of group projects. This course is intended primarily for students wishing to pursue a career in the pharmaceutical industry or in national regulatory bodies, but may have more general interest as an applied mid-level course with a heavy methodological emphasis.
Course Activities: Written and oral group projects, individual class presentations, class discussion.
Course Note: Knowledge of epidemiology at the level of EPI 202 and a basic understanding of drug use and nomenclature are assumed; completion of EPI203 preferred; enrollment limited to 25 students; signature of instructor required; course meets Monday through Thursday, 1:30 pm to 4 pm during WinterSession. (5.06)

Course evaluations are an important method for feedback on the quality of course offerings. The submission of a course evaluation is a requirement for this course. Your grade for the course will be made available only after you have submitted responses to at least the first three questions of the on-line evaluation for this course.

Copyright © 2012 The President and Fellows of Harvard College